144 related articles for article (PubMed ID: 15681534)
1. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype.
Williamson D; Lu YJ; Gordon T; Sciot R; Kelsey A; Fisher C; Poremba C; Anderson J; Pritchard-Jones K; Shipley J
J Clin Oncol; 2005 Feb; 23(4):880-8. PubMed ID: 15681534
[TBL] [Abstract][Full Text] [Related]
2. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
3. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
[TBL] [Abstract][Full Text] [Related]
4. Identification of MYCN Copy Number Heterogeneity by Direct FISH Analysis of Neuroblastoma Preparations.
Squire JA; Thorner P; Marrano P; Parkinson D; Ng YK; Gerrie B; Chilton-Macneill S; Zielenska M
Mol Diagn; 1996 Dec; 1(4):281-289. PubMed ID: 10462574
[TBL] [Abstract][Full Text] [Related]
5. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
[TBL] [Abstract][Full Text] [Related]
6. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Spitz R; Hero B; Skowron M; Ernestus K; Berthold F
Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
Valent A; Guillaud-Bataille M; Farra C; Lozach F; Spengler B; Terrier-Lacombe MJ; Valteau-Couanet D; Danglot G; Lenoir GM; Brison O; Bénard J; Bernheim A
Cancer Genet Cytogenet; 2004 Aug; 153(1):10-5. PubMed ID: 15325088
[TBL] [Abstract][Full Text] [Related]
8. Solid variant of alveolar rhabdomyosarcoma with unbalanced t(2;13) and hypotetraploidy, without MYCN amplification.
Smith A; Sharma P; Tomlinson J; Robson L; Goldrick A
Pathology; 2001 Feb; 33(1):108-11. PubMed ID: 11280599
[TBL] [Abstract][Full Text] [Related]
9. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
[TBL] [Abstract][Full Text] [Related]
10. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
11. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
[TBL] [Abstract][Full Text] [Related]
12. Genes, chromosomes, and rhabdomyosarcoma.
Anderson J; Gordon A; Pritchard-Jones K; Shipley J
Genes Chromosomes Cancer; 1999 Dec; 26(4):275-85. PubMed ID: 10534762
[TBL] [Abstract][Full Text] [Related]
13. Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma.
Gallego S; Reventos J; Sanchez de Toledo J; Munell F
Anticancer Res; 1998; 18(2A):1211-5. PubMed ID: 9615790
[TBL] [Abstract][Full Text] [Related]
14. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma.
Gordon AT; Brinkschmidt C; Anderson J; Coleman N; Dockhorn-Dworniczak B; Pritchard-Jones K; Shipley J
Genes Chromosomes Cancer; 2000 Jun; 28(2):220-6. PubMed ID: 10825007
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
[TBL] [Abstract][Full Text] [Related]
17. Gene alterations and apoptosis in rhabdomyosarcoma.
Boman F; Brel D; Antunes L; Alhamany Z; Floquet J; Boccon-Gibod L
Pediatr Pathol Lab Med; 1997; 17(2):233-47. PubMed ID: 9086530
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
[TBL] [Abstract][Full Text] [Related]
19. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
20. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis.
Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
